Bakkenolide G, a Natural PAF-receptor Antagonist

Autor: Che-Ming Teng, Feng Nien Ko, Chang-Hui Liao, Tian Shung Wu
Rok vydání: 1997
Předmět:
Zdroj: Journal of Pharmacy and Pharmacology. 49:1248-1253
ISSN: 2042-7158
0022-3573
DOI: 10.1111/j.2042-7158.1997.tb06079.x
Popis: Because platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) participates in many physiopathological responses, including inflammatory reaction, endotoxic shock, allergic diseases and platelet aggregation, PAF-receptor antagonists are important in the treatment of these diseases. A biologically active compound, bakkenolide G, extracted from the plant Petasites formosanus selectively and concentration-dependently inhibited PAF-induced platelet aggregation and ATP release. The IC50 of bakkenolide G for PAF (2 ng mL−1)-induced platelet aggregation was 5.6 ± 0.9 μm. Bakkenolide G also concentration-dependently inhibited PAF-induced intracellular signal transductions, including thromboxane B2 formation, and increased intra-cellular calcium concentration and phosphoinositide breakdown without affecting those caused by thrombin (01 units mL−1), collagen (10 μg mL−1), arachidonic acid (100 μm) and U46619 (1 μm). Bakkenolide G shifted the concentration-response curves of PAF-induced platelet aggregation parallel to the right; the Schild plot slope and the pA2 value were 1.31 ± 0.31 and 6.21 ± 0.75, respectively. Moreover, bakkenolide G concentration-dependently competed with [3H]PAF binding to platelets, with an IC50 value of 2.5 ± 0.4 μm. These data strongly indicate that bakkenolide G is a specific PAF-receptor antagonist as an antiplatelet aggregatory agent.
Databáze: OpenAIRE